Q1 FY27 results show revenue dip; Rs 1.2 dividend, Rs 800 cr QIP raise

Revenue declinedResults View source PDF Explain this filing

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹625.00

prior close

₹591.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+1.4%-7.2% vs market

Pharmaceuticals peers, median of 163sector+1.0%-6.8% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Smallcap 250 and 6.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

-0.6

15m

+0.1

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8+1.4-7.2+1.0-6.8

Next day

-6.7+1.5-8.3+0.8-7.5

-4.8+2.2-7.0+0.3-5.1

-5.9+2.4-8.4+0.7-6.7

-5.1+2.4-7.6+1.5-6.6

-5.3+2.4-7.7+1.3-6.6

-5.9+2.3-8.2+1.6-7.6

15d

-5.4+2.5-8.0+0.9-6.3

-7.5+2.9-10.4+1.7-9.2

-14.8-1.5-13.3+1.9-16.7

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare Q1 FY27 revenue fell 17% YoY to Rs 293.11 cr from Rs 354.76 cr. PAT dipped 14% to Rs 78.26 cr (EPS Rs 4.51 vs Rs 5.26). Board set Sept 14 record date for Rs 1.2 per share dividend for FY26. Re-appointed Executive Chairman and MD for 5 years each, and auditor KKC for a second 5-year term. Post-quarter, raised Rs 800 cr via QIP at Rs 506 per share.

Likely market impact

Weak Q1 with revenue and PAT decline, but Rs 1.2 dividend and Rs 800 cr QIP raise strengthen balance sheet.